Phase Ii Clinical Trial Of One Dose Of Post-Transplant Cyclophosphamide For Graft Versus Host Disease Prevention Following Myeloablative, Peripheral Blood Stem Cell, Matched-Unrelated Donor Transplantation
AMERICAN JOURNAL OF HEMATOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要